Ignite Creation Date:
2024-05-05 @ 6:30 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00494897
Status:
COMPLETED
Last Update Posted:
2009-05-19
First Post:
2007-06-29
Brief Title:
PETHEMA LAL-RI96 Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia
Sponsor:
PETHEMA Foundation
Organization:
PETHEMA Foundation
Organization Data
Organization:
PETHEMA Foundation
Class:
OTHER
Study ID:
LAL-RI96
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PETHEMA Foundation
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Pethema
Old Organization:
pethema